Ticker > Company >

Indo US Bio-Tech share price

Indo US Bio-Tech Ltd.

NSE: INDOUS BSE: 541304 SECTOR: Agriculture  23k   95   5

289.85
-25.00 (-7.94%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 328.5

Today's Low

₹ 280.15

52 Week High

₹ 386

52 Week Low

₹ 180

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

581.21 Cr.

Enterprise Value

594.43 Cr.

No. of Shares

2.01 Cr.

P/E

49.51

P/B

8.27

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  35.03

CASH

1.1 Cr.

DEBT

14.32 Cr.

Promoter Holding

70.17 %

EPS (TTM)

₹  5.85

Sales Growth

17.96%

ROE

14.08 %

ROCE

14.42%

Profit Growth

13.96 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.96%
3 Year22.02%
5 Year15.46%

Profit Growth

1 Year13.96%
3 Year17.41%
5 Year31.63%

ROE%

1 Year14.08%
3 Year15.64%
5 Year18.11%

ROCE %

1 Year14.42%
3 Year14.97%
5 Year15.97%

Debt/Equity

0.2283

Price to Cash Flow

-126.85

Interest Cover Ratio

6.7944

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 70.17 0.00
Jun 2024 70.17 0.00
Mar 2024 70.17 0.00
Dec 2023 70.17 0.00
Sep 2023 70.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 17.4112738760856% for the Past 3 years.
  • The company has shown a good revenue growth of 22.024452321853% for the Past 3 years.
  • Company has a healthy liquidity position with current ratio of 4.1853.
  • The company has a high promoter holding of 70.17%.

 Limitations

  • Company has negative cash flow from operations of -4.5819814.
  • Tax rate is low at 6.2808.
  • The company is trading at a high PE of 49.51.
  • The company is trading at a high EV/EBITDA of 41.4726.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 15.81 22.11 15.77 24.72 22.17
Total Expenditure 13.22 17.87 14.8 21.03 17.05
Operating Profit 2.59 4.24 0.97 3.69 5.12
Other Income 0 0.08 0.21 0.03 0.02
Interest 0.41 0.37 0.36 0.33 0.52
Depreciation 0.21 0.19 0.2 0.2 0.18
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.98 3.75 0.63 3.19 4.45
Tax 0.31 0.07 0.11 0.02 0.09
Profit After Tax 1.67 3.69 0.52 3.17 4.36
Adjusted EPS (Rs) 0.83 1.84 0.26 1.58 2.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 39.76 40.09 50.05 61.74 72.84
Total Expenditure 35.8 34.57 43.12 52.35 62.03
Operating Profit 3.96 5.51 6.93 9.39 10.8
Other Income 0.01 0.04 0.18 0.02 0.32
Interest 0.88 1.18 1.2 1.2 1.52
Depreciation 0.21 0.25 0.42 0.83 0.8
Exceptional Items -0.01 0 0 0 0
Profit Before Tax 2.86 4.13 5.49 7.39 8.8
Tax 0.33 -0.97 0.25 0.15 0.55
Net Profit 2.53 5.1 5.24 7.24 8.25
Adjusted EPS (Rs.) 1.74 3.5 2.86 3.61 4.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.07 6.07 9.17 10.03 20.05
Total Reserves 10.37 15.47 29.71 44.47 42.7
Borrowings 0.8 3.36 3.4 1.7 2.8
Other N/C liabilities 0.73 0.56 0.68 0.39 0.78
Current liabilities 16.73 17.96 12.21 12.29 17.46
Total Liabilities 34.7 43.42 55.16 68.88 83.8
Assets
Net Block 1.41 2.33 5.54 7.37 6.69
Capital WIP 1.28 1.99 2.32 1.37 3.78
Intangible WIP 0 0 0 0 0
Investments 0 0.01 0.01 0 0
Loans & Advances 0.08 0.94 0.23 0.24 0.24
Other N/C Assets 0.03 0.01 0 0 0
Current Assets 31.9 38.13 47.06 59.91 73.09
Total Assets 34.7 43.42 55.16 68.88 83.8
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.86 4.13 5.49 7.39 8.8
Adjustment 1.1 1.42 1.62 2.02 2.25
Changes in Assets & Liabilities -4.77 -5.19 -3.81 -8.56 -15.32
Tax Paid -0.03 -0.14 -0.39 -0.31 -0.31
Operating Cash Flow -0.84 0.22 2.91 0.53 -4.58
Investing Cash Flow -0.57 -1.75 -5.4 -6.67 4.28
Financing Cash Flow 1.53 1.46 2.41 6.29 1.22
Net Cash Flow 0.12 -0.07 -0.08 0.14 0.91

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 70.17 70.17 70.17 70.17 70.17
ajudia jagdish devjibhai ... 5.74 5.74 5.74 5.74 5.74
indo us agriseeds limited... - 10.71 10.71 10.71 10.71
jagdishkumar devjibhai aj... 48.82 48.82 48.82 48.82 48.82
malti jagdishbhai ajudia 2.91 2.91 2.91 2.91 2.91
priyanka jagdishbhai ajud... 1.99 1.99 1.99 1.99 1.99
indo us agriseeds private... 10.71 - - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 29.83 29.83 29.83 29.83 29.83
aumit capital advisors li... 1.11 1.08 1.08 1.08 1.18
improwised technologies p... 1.99 1.99 1.99 1.99 1.99
natvarsinh t chavda . 1.11 1.11 1.10 1.10 1.10
nitin dalpatlal shah 1.65 1.65 1.06 1.06 1.06
pratik rajendrabhai gandh... 1.50 1.50 1.50 1.50 1.50
himanshu chinubhai shah 1.01 1.01 - - -
manisha nitinkumar shah 1.43 1.43 - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Indo US Bio-Tech informs about certificate of appreciation 11 Sep, 5:30 PM Indo US Bio-Tech - Quaterly Results 8 Aug, 12:00 PM Indo US Bio-Tech - Quaterly Results 8 Aug, 12:00 PM Indo US Bio-Tech - Quaterly Results 8 Aug, 12:00 PM Indo Us Bio-Tech informs about clarification 21 Jun, 9:50 AM Indo US Bio-Tech - Quaterly Results 2 May, 5:38 PM Indo US Bio-Tech - Quaterly Results 2 May, 5:38 PM Indo US Bio-Tech - Quaterly Results 2 May, 5:38 PM Indo Us Bio-Tech informs about disclosure 24 Apr, 6:04 PM Indo US Bio-Tech - Quaterly Results 14 Feb, 4:43 PM Indo US Bio-Tech - Quaterly Results 14 Feb, 4:43 PM Indo Us Bio-Tech informs about compliances-certificate 11 Jan, 5:19 PM Indo US Bio Tech enters into RCO with Chhattisgarh State Seed and Agriculture Development Corporation 24 Aug, 3:37 PM Indo Us Bio Tech informs about disclosure 24 Aug, 3:10 PM Indo US Bio-Tech - Quaterly Results 12 Aug, 7:01 PM Indo US Bio-Tech - Quaterly Results 12 Aug, 7:01 PM Indo Us Bio-Tech informs about outcome of board meeting 7 Jul, 5:10 PM Indo Us Bio-Tech informs about compliance certificate 5 Apr, 4:38 PM Indo US Bio-Tech gets nod to transfer 98.5% stake of subsidiary company 29 Jul, 4:58 PM Indo Us Bio-Tech informs about allotment of bonus shares 30 Nov, 3:05 PM Indo Us Bio-Tech informs about compliance certificate 7 Oct, 3:54 PM Indo US Bio-Tech informs about annual report 7 Sep, 4:47 PM Indo US Bio-Tech enters into agreement with NAFED 10 Jul, 5:31 PM Indo Us Bio-Teach incorporates subsidiary 17 Jun, 10:02 AM

Indo US Bio-Tech Stock Price Analysis and Quick Research Report. Is Indo US Bio-Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Indo US Bio-Tech stock price today is Rs 288.55. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Indo US Bio-Tech . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indo US Bio-Tech has a PE ratio of 49.292767091462 which is high and comparatively overvalued .

  • Share Price: - The current share price of Indo US Bio-Tech is Rs 288.55. One can use valuation calculators of ticker to know if Indo US Bio-Tech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indo US Bio-Tech has ROA of 10.8089 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indo US Bio-Tech has a Current ratio of 4.1853 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indo US Bio-Tech has a ROE of 14.0757 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indo US Bio-Tech has a Debt to Equity ratio of 0.2283 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Indo US Bio-Tech has reported revenue growth of 17.9635 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indo US Bio-Tech for the current financial year is 14.834319528447 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indo US Bio-Tech is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Indo US Bio-Tech is Rs 5.8538 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Indo US Bio-Tech in Ticker for free. Also, one can get the intrinsic value of Indo US Bio-Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Indo US Bio-Tech
X